The market is segmented based on Segmentation, By Therapeutics (Progestogens, Corticosteroids, Combination Therapies, and Others), Mechanism of Action (Appetite Stimulators, Weight Loss Stabilizers, and Others), Distribution Channel (Hospital Stores, Retail Pharmacy Stores, and Online Pharmacy) – Industry Trends and Forecast to 2032
.
The Global Cancer Cachexia Market size was valued at USD 2.53 USD Billion in 2024.
The Global Cancer Cachexia Market is projected to grow at a CAGR of 4.65% during the forecast period of 2025 to 2032.
The major players operating in the market include Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corp, Eli Lilly and Co., GTx Inc., Helsinn Group, Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio PharmaceuticalsInc., Astellas Pharma Inc., AstraZeneca PLC, Biotest AG, Boehringer Ingelheim GmbH, Boston Biomedical, InteRNA Technologies B.V., ISU ABXIS Co.Ltd., AVEO PharmaceuticalsInc., Jiangsu Kanion Pharmaceutical Co.Ltd. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.